Recombinant GFRA3 (Nadecnemab Biosimilar) antibody
Research Grade
Reactivity: Human
Host: Human
Monoclonal
unconjugated
Recombinant Antibody
-
- Target See all GFRA3 (Nadecnemab Biosimilar) products
- GFRA3 (Nadecnemab Biosimilar)
- Antibody Type
- Recombinant Antibody
- Reactivity
- Human
-
Host
-
Human
- Expression System
- Mammalian cells
-
Clonality
- Monoclonal
-
Conjugate
- This GFRA3 (Nadecnemab Biosimilar) antibody is un-conjugated
- Application
- Please inquire
- Purpose
- Research Grade Nadecnemab Biosimilar Antibody
- Specificity
- GFR-alpha-3, GDNF receptor alpha-3, GDNF family receptor alpha-3, GDNFR-alpha-3, GFRA3
- Purification
- Protein A or G purified from cell culture supernatant.
- Purity
- >95 % by SDS-PAGE.
- Grade
- Research Grade
- Isotype
- IgG4 kappa
-
anti-GFRA3 (Nadecnemab Biosimilar) antibody
Research Grade Reactivity: Human ELISA, FACS Host: Human Monoclonal unconjugated Recombinant Antibody
-
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 1 mg/mL
- Buffer
- 0.01M PBS, pH 7.4.
- Storage
- 4 °C,-20 °C,-80 °C
- Storage Comment
- Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.
- Expiry Date
- 12 months
-
- Target
- GFRA3 (Nadecnemab Biosimilar)
- Alternative Name
- Nadecnemab Biosimilar (GFRA3 (Nadecnemab Biosimilar) Products)
- Target Type
- Biosimilar
- Background
- GFR-alpha-3, GDNF receptor alpha-3, GDNF family receptor alpha-3, GDNFR-alpha-3, GFRA3
- UniProt
- O60609
- CAS-No
- 2377679-19-9
-
You are here:
